Get Ready for New Options to Treat Seasonal Allergies
May 2022
You’ll see a plethora of new products and Rx-to-OTC switches for seasonal allergies.
Ryaltris (olopatadine/mometasone) will be a new Rx nasal spray.
Lastacaft (alcaftadine) eye drops have now switched from Rx to OTC. Nasonex (mometasone) nasal spray will switch later this year...so will Astepro 0.15% (azelastine), the first nasal antihistamine to go OTC.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote